34th Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium (TCT 2022)

Does cerebral embolic protection reduce stroke risk post-TAVR?

Roshini Claire Anthony, 20221027180001

The use of a cerebral embolic protection (CEP) device did not reduce the risk of periprocedural stroke in patients undergoing transcatheter aortic valve replacement (TAVR), according to results of the PROTECTED TAVR study presented at TCT 2022.

Amphilimus- vs zotarolimus-eluting stents: Any preference in patients with diabetes?

Roshini Claire Anthony, 20221020180001

Updated results of the SUGAR* trial showed that using polymer-free amphilimus-eluting stents (AES) was not a superior option to durable-polymer zotarolimus-eluting stents (ZES) in patients with diabetes mellitus who required percutaneous coronary intervention (PCI).

Rivaroxaban cuts radial artery occlusion rates

Elvira Manzano, 20221019000000

Rivaroxaban reduces radial artery occlusion rate, without significantly increasing bleeds, in patients undergoing transradial coronary procedures in the RIVARAD study.

Alirocumab prior to PCI lowers LDL-C

Elvira Manzano, 20221018000000

Starting alirocumab early in the hospital prior to undergoing percutaneous coronary intervention (PCI) reduces LDL-cholesterol (LDL-C) in STEMI* patients already on high-statin therapy.

Updated BEST results: No major difference between EES or CABG for multivessel disease

Roshini Claire Anthony, 20221014180001

In patients with multivessel coronary artery disease, the risk of any-cause death, myocardial infarction (MI), or target vessel revascularization (TVR) did not vary according to whether patients underwent percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) or coronary artery bypass graft (CABG), extended follow-up of the BEST* trial showed.

PASCAL System augments treatment armamentarium for severe mitral regurgitation

Audrey Abella, 20221006100000

In the CLASP* IID trial, the PASCAL Transcatheter Valve Repair System demonstrated noninferiority to the MitraClip System for the treatment of severe symptomatic degenerative mitral regurgitation (DMR).

Bashir catheter shows treatment potential for pulmonary embolism

Audrey Abella, 20221005100000

Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.

Renal denervation bounces back in 3-year follow-up study

Audrey Abella, 20220929100000

Following negative primary results, the final follow-up of the SYMPLICITY HTN-3 trial takes a turn for the better, demonstrating significant blood pressure (BP) reductions with renal denervation (RDN) in patients with uncontrolled hypertension (HTN).